Labajo, Erbien G.
HRN: 23-60-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/27/2023
09/03/2023
ORAL
3.5ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes